Humoral immunity to HIV, SIV, and SHIV.
Haigwood
N L
NL
Seattle Biomedical Research Institute, WA 98121, USA.
Zolla-Pazner
S
S
D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000917:Antibody Formation; D004195:Disease Models, Animal; D015483:HIV Antibodies / Q000096:biosynthesis*; D015488:HIV Antigens / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive; D016086:Lentivirus; D016865:Reassortant Viruses / Q000276:immunology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000276:immunology; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000276:immunology
D016915:AIDS Vaccines; D000914:Antibodies, Viral; D015483:HIV Antibodies; D015488:HIV Antigens; D015700:HIV Envelope Protein gp41; D014613:Vaccines, Attenuated